Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $7.4000 (-13.04%) ($7.3800 - $7.4000) on Mon. Jul. 11, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.41% (three month average) | RSI | 69 | Latest Price | $7.4000(-13.04%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -2.2% a day on average for past five trading days. | Weekly Trend | ATRA advances 11.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) ARKK(30%) XLI(28%) XAR(34%) IVE(32%) JETS(32%) | Factors Impacting ATRA price | ATRA will decline at least -3.205% in a week (0% probabilities). UNG(-26%) TIP(-16%) USO(-15%) TLT(-15%) CEMB(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.205% (StdDev 6.41%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.39(-11.8%) | 10 Day Moving Average | $7.95(-6.92%) | 20 Day Moving Average | $7.03(5.26%) | To recent high | -15% | To recent low | 57.8% | Market Cap | $550m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |